康宁(GLW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLW 康宁

盘前交易 07-03 04:33:37 EDT

38.39

-0.27

-0.70%

最高38.90	最低38.15	成交量627.17万
今开38.67	昨收38.66	日振幅1.94%
总市值328.86亿	流通市值296.70亿	总股本8.57亿
成交额2.41亿	换手率0.81%	流通股本7.73亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLW","market":"US","secType":"STK","nameCN":"康宁","latestPrice":38.39,"timestamp":1719950400000,"preClose":38.66,"halted":0,"volume":6271722,"delay":0,"floatShares":772845117,"shares":856619222,"eps":0.720209,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.27,"latestTime":"07-03 04:33:37 EDT","open":38.67,"high":38.9,"low":38.15,"amount":240921050.86692,"amplitude":0.0194,"askPrice":38.62,"askSize":150,"bidPrice":38.16,"bidSize":2,"shortable":3,"etf":0,"ttmEps":0.720209,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1720013400000},"adr":0,"adjPreClose":38.39,"adrRate":0,"dividendRate":0.029174,"postHourTrading":{"tag":"盘后","latestPrice":38.39,"preClose":38.39,"latestTime":"19:58 EDT","volume":137807,"amount":5290336.1374,"timestamp":1719964723972},"volumeRatio":0.6927394968907742,"impliedVol":0.277,"impliedVolPercentile":0.9044},"requestUrl":"/m/hq/s/GLW","defaultTab":"news","newsList":[{"id":"2448611075","title":"南向资金7月2日净卖出康宁杰瑞制药-B1.90万股 连续7日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2448611075","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448611075?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:31","pubTimestamp":1719970301,"startTime":"0","endTime":"0","summary":"7月2日，南向资金减持康宁杰瑞制药-B1.90万股连续7日减持。截止当日收盘，港股通共持有康宁杰瑞制药-B25690.84万股，占流通股26.62%。港股通减持金额前五个股分别为腾讯控股、李宁、中国海洋石油、香港交易所、中广核电力。康宁杰瑞制药-B近5个交易日下跌2.07%，港股通累计减持254.60万股；近20个交易日下跌7.09%，港股通累计减持1074.40万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030942329ef87814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030942329ef87814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLW","LU0348723411.USD","YANG","BK4588","BK4512","BK4148","BK4585"],"gpt_icon":0},{"id":"2448157409","title":"康宁杰瑞PD-L1海外临床失败，翻盘概率渺茫","url":"https://stock-news.laohu8.com/highlight/detail?id=2448157409","media":"健识局","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448157409?lang=zh_cn&edition=full","pubTime":"2024-07-02 22:06","pubTimestamp":1719929205,"startTime":"0","endTime":"0","summary":"就在5月29日，康宁杰瑞另一核心产品KN046针对晚期胰腺导管癌临床试验失败。PD-L1美国临床失败康宁杰瑞出海遇阻7月1日，美国制药公司TRACON宣布，将终止恩沃利单抗的进一步开发。恩沃利单抗注是康宁杰瑞自主研发的PD-L1单抗，相比于其他竞品的最大亮点在于剂型为皮下注射。就在不久前，康宁杰瑞的核心产品PD-L1/CTLA-4双抗KN046刚刚遭遇了一场重大失利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022210319566f7b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022210319566f7b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348723411.USD","LU1169589451.USD","GLW","BK4023","PD","LU1169590202.USD","BK4588","BK4585","BK4148","BK4512"],"gpt_icon":0},{"id":"2444974951","title":"康宁盘中异动 下午盘急速拉升5.05%报39.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444974951","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444974951?lang=zh_cn&edition=full","pubTime":"2024-06-18 01:13","pubTimestamp":1718644396,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日01时13分，康宁股票出现异动，股价快速上涨5.05%。截至发稿，该股报39.13美元/股，成交量524.004万股，换手率0.61%，振幅3.17%。最近的财报数据显示，该股实现营业收入29.75亿美元，净利润2.09亿美元，每股收益0.25美元，毛利9.63亿美元，市盈率54.29倍。康宁股票所在的电子元器件行业中，整体涨幅为1.50%。消息层面，截至01时13分，康宁股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618011316af8de67d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618011316af8de67d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4512","BK4148","GLW","LU0348723411.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2443069705","title":"BUZZ-摩根士丹利下调康宁评级至 \"等权重 \"后，康宁走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2443069705","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443069705?lang=zh_cn&edition=full","pubTime":"2024-06-13 18:51","pubTimestamp":1718275886,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    6月13日 - ** 玻璃制造商康宁  股价盘前下跌 ~1.2%，报 37.55 美元** 摩根士丹利将康宁股票评级从 \"增持 \"下调至 \"等权重\"。** 产生大部分盈利的显示器业务运营高效。然而，消费业务复苏缓慢。** 不过，券商将其目标价从 35 美元上调至 38 美元。** 16 家券商对 GLW 的平均建议是 \"买入\"，他们的目标价中位数为 37.01 美元 - LSEG 数据** 年初至今，股价上涨约 24.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLW","BUZZ"],"gpt_icon":0},{"id":"2443783975","title":"美国研究综述-Avidity Biosciences、Broadcom、Cara Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2443783975","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443783975?lang=zh_cn&edition=full","pubTime":"2024-06-13 15:24","pubTimestamp":1718263489,"startTime":"0","endTime":"0","summary":"    路透6月13日 - 华尔街证券分析师周四修改了对几家美国上市公司的评级和目标价，其中包括 Avidity Biosciences、Broadcom 和 Cara Therapeutics。要点             * Avidity Biosciences Inc   ：Leerink Partners将目标价从38美元上调至56美元             * Broadcom Inc   ：TD Cowen将目标价从1500美元上调至1750美元              * Cara Therapeutics Inc   ：Canaccord Genuity将目标价从 \"买入 \"下调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0097036916.USD","LU0444971666.USD","LU0320765489.SGD","AVGO","LU1670711040.USD","BK4088","LU0466842654.USD","LU1244550494.USD","BK4533","GLW","LU1992135399.USD","LU1670628061.USD","AVGOP","LU0820561818.USD","LU1720051108.HKD","LXEO","LU0170899867.USD","LU2065731478.USD","LU1242518931.SGD","MTH","IE00BMPRXN33.USD","SG9999018865.SGD","APH","ENOV","SG9999014898.SGD","IE00B19Z6F94.USD","LU0689472784.USD","LU2065732104.USD","LU0056508442.USD","LU0957808578.USD","LU1670710588.SGD","CELH","RNA","CASY","LU1242518857.USD","LU1670711123.USD","TWST","WMB","CRL","LENZ","LU1670627923.USD","LU0198837287.USD","LU1720051017.SGD","LU0820561909.HKD","LU0861579265.USD","LU1670710661.SGD","CARA","LU1642822529.SGD","BK4082","IE00BD6J9T35.USD"],"gpt_icon":0},{"id":"2441267030","title":"德龙激光(688170.SH)：终止收购德国康宁激光100%股权事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2441267030","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441267030?lang=zh_cn&edition=full","pubTime":"2024-06-07 17:41","pubTimestamp":1717753262,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德龙激光 发布公告，2023年11月8日，公司与Corning International Corporation签订了《关于出售和转让Corning Laser Technologies GmbH所有股权及部分资产的协议》，公司拟购买康宁国际持有的Corning Laser Technologies GmbH100%股权及部分资产。自公司首次公告本次收购事项以来，各方均积极推进中国、美国及德国相关政府机构审批或备案相关工作和并购交割后的整合准备工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4512","BK4585","688170","BK0251","LU0348723411.USD","GLW","BK4148","BK4588"],"gpt_icon":0},{"id":"2441794286","title":"康宁杰瑞与 Arrivent 合作开发 ADC 新药；BMS免疫疗法组合3期试验结果积极;35家医药企业上榜世界500强","url":"https://stock-news.laohu8.com/highlight/detail?id=2441794286","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441794286?lang=zh_cn&edition=full","pubTime":"2024-06-06 18:18","pubTimestamp":1717669089,"startTime":"0","endTime":"0","summary":"根据合作协议的条款，康宁杰瑞将与 ArriVent 合作，使用康宁杰瑞专有的连接子载荷平台  及糖基定点偶联平台，以发现及开发 ADC 新药。在大中华区以外的国家和地区，ArriVent 将拥有相关 ADC 产品于肿瘤领域的开发及商业化的独家权利，并将负责及承担 ADC 产品的相应开发费用支出。此外，康宁杰瑞亦有权就各 ADC 产品向 ArriVent 收取分级销售特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406061826379594867d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406061826379594867d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4231","GLW","BK4585","BK4148","ADC","BMS","BK4080","BK4588","LU0348723411.USD","BK4512"],"gpt_icon":0},{"id":"2441730726","title":"康宁杰瑞与ArriVent就ADC产品研发和商业化达成合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2441730726","media":"美通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441730726?lang=zh_cn&edition=full","pubTime":"2024-06-06 10:19","pubTimestamp":1717640340,"startTime":"0","endTime":"0","summary":"在大中华区以外的国家和地区，ArriVent将拥有相关ADC产品肿瘤领域的开发及商业化的独家权利，并将负责及承担ADC产品的相应开发费用支出。根据协议条款，康宁杰瑞有权收取一次性、不可退还的预付款，以及潜在的里程碑付款，包括产品注册、开发及销售里程碑款项，总计高达6.155亿美元。此外，康宁杰瑞还有权就各ADC产品向ArriVent收取分级销售特许权使用费。此次合作结合了康宁杰瑞ADC药物的研发能力和ArriVent在肿瘤领域丰富的开发经验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4433095_ZH33095_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["09966","ADC","BK4231","BK1574","BK4585","GLW","BK1161","LU0348723411.USD","BK4080","BK4588","BK4148","BK4512"],"gpt_icon":0},{"id":"2441204719","title":"康宁推出大猩猩玻璃7i：OPPO全球首发","url":"https://stock-news.laohu8.com/highlight/detail?id=2441204719","media":"PConline太平洋...","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441204719?lang=zh_cn&edition=full","pubTime":"2024-06-05 17:56","pubTimestamp":1717581381,"startTime":"0","endTime":"0","summary":"大猩猩玻璃7i将以其实惠的价格，为中高端设备带来显著的耐用性提升。康宁公司此次推出升级版，意在满足市场对于更高性能玻璃的需求。经过康宁公司实验室的严格测试，大猩猩玻璃7i成功通过了沥青路面上1米的跌落测试，而竞品铝硅酸锂玻璃则未能通过。OPPO公司将成为全球首家采用大猩猩玻璃7i的厂商，这意味着OPPO的新款智能手机将率先搭载这款强化玻璃，为用户提供更耐用的设备选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406051757399f1c61b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406051757399f1c61b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","GLW","BK4512","BK4148","LU0348723411.USD","BK4585"],"gpt_icon":0},{"id":"2441213867","title":"康宁发布大猩猩7i盖板玻璃 提供更好的跌落保护和抗刮擦性能","url":"https://stock-news.laohu8.com/highlight/detail?id=2441213867","media":"IT 商业新闻网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441213867?lang=zh_cn&edition=full","pubTime":"2024-06-05 11:43","pubTimestamp":1717558982,"startTime":"0","endTime":"0","summary":"原标题：康宁发布大猩猩 7i 盖板玻璃：服务中端手机，1 米跌落无伤　　6 月 5 日消息，康宁公司今天发布新闻稿，专...","market":"us","thumbnail":"https://q5.itc.cn/q_70/images03/20240605/3639ed9dc40a44ba8e1926c6a37c6a2a.jpeg","type":0,"news_type":0,"thumbnails":["https://q5.itc.cn/q_70/images03/20240605/3639ed9dc40a44ba8e1926c6a37c6a2a.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.itxinwen.com/mobile/20240605/153744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"itxinwen_highlight","symbols":["BK4512","BK4148","GLW","BK4585","LU0348723411.USD","BK4588"],"gpt_icon":0},{"id":"2440481669","title":"康宁杰瑞HER2双抗ADC药物JSKN003中国临床研究数据首次亮相2024年ASCO年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2440481669","media":"美通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440481669?lang=zh_cn&edition=full","pubTime":"2024-06-03 10:17","pubTimestamp":1717381020,"startTime":"0","endTime":"0","summary":"本次ASCO年会上报道的是JSKN003-102的I期临床研究结果。苏州2024年6月3日 /美通社/ -- 康宁杰瑞生物制药宣布，HER2双抗偶联药物JSKN003治疗HER2表达实体瘤的中国Ⅰ期临床研究数据，在2024年美国临床肿瘤学会年会上首次公布。目前JSKN003在澳大利亚和中国的多项临床研究正在顺利进行，治疗晚期HER2低表达乳腺癌的中国关键临床研究在积极推进中。游离毒素的暴露量显著低于JSKN003，显示JSKN003在体内循环系统中稳定性较好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4429196_ZH29196_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["09966","ADC","BK4512","LU0348723411.USD","BK1161","GLW","BK1574","BK4231","BK4585","BK4080","BK4148","BK4588"],"gpt_icon":0},{"id":"2440480989","title":"核心产品失利后，康宁杰瑞市值缩水近半","url":"https://stock-news.laohu8.com/highlight/detail?id=2440480989","media":"国际金融报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440480989?lang=zh_cn&edition=full","pubTime":"2024-06-01 01:05","pubTimestamp":1717175159,"startTime":"0","endTime":"0","summary":"5月29日，港交所上市公司康宁杰瑞盘中股价暴跌，最大跌幅达58%。因此，若KN046临床成功，于患者，于康宁杰瑞而言都将有重大的意义。2023年11月，康宁杰瑞股价大跌，市值缩水至90亿港元左右。临床试验失败消息传出后，康宁杰瑞的市值已缩水近半。2023年年报数据显示，康宁杰瑞的研发投入已进行削减，全年研发投入40.75亿元，同比下降12.97%。但截至去年末，康宁杰瑞现金储备仅余14.07亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406010120239580a8a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406010120239580a8a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4512","BK4148","GLW","LU0348723411.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2439954669","title":"康宁杰瑞明星抗癌药再遇挫折 市值已跌超九成","url":"https://stock-news.laohu8.com/highlight/detail?id=2439954669","media":"华夏时报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439954669?lang=zh_cn&edition=full","pubTime":"2024-05-31 16:22","pubTimestamp":1717143758,"startTime":"0","endTime":"0","summary":"5月28日晚间，康宁杰瑞宣布，其明星候选产品PD-L1/CTLA-4双抗KN046治疗晚期胰腺导管腺癌（PDAC）的III期临床试验失败。次日，公司股价暴跌，盘中最大跌幅达58%。截至5月30日收盘，康宁杰瑞总市值降至23.45亿港元，较其历史最高市值259.69亿港元，已缩水超九成。值得注意的是，KN046-303的研发失利疑似早在去年11月就已经泄露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202405313092465932.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202405313092465932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0348723411.USD","BK4585","BK4512","GLW","BK4588","BK4148"],"gpt_icon":0},{"id":"2439259426","title":"小摩：上调Corning(GLW.US)评级，由中性调整至增持评级, 目标价由37.00美元调整至43.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439259426","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439259426?lang=zh_cn&edition=full","pubTime":"2024-05-30 22:35","pubTimestamp":1717079751,"startTime":"0","endTime":"0","summary":"小摩：上调Corning(GLW.US)评级，由中性调整至增持评级, 目标价由37.00美元调整至43.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302235559f05ca25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405302235559f05ca25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLW"],"gpt_icon":0},{"id":"2439618677","title":"重磅管线临床失利致市值缩水近九成，康宁杰瑞还有翻盘机会？","url":"https://stock-news.laohu8.com/highlight/detail?id=2439618677","media":"21财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439618677?lang=zh_cn&edition=full","pubTime":"2024-05-30 17:21","pubTimestamp":1717060860,"startTime":"0","endTime":"0","summary":"5月29日，康宁杰瑞股价跌幅达44.75%，5月30日继续下跌7.6%，总市值降至23.45亿港元，较历史最高市值259.69亿港元缩水逾九成。同时，超过80%的胰腺癌患者因病期较晚而失去手术机会。而此次KN046在PDAC临床的失败成为此现象的又一验证。截至2023年底，康宁杰瑞现金储备为14.07亿元。同时，津曼特生物将与江苏康宁杰瑞共同开发KN026其他适应症，包括KN026单药及组合用药。这些授权许可或将为康宁杰瑞提供一定的现金支持。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530172731af8b1db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530172731af8b1db2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348723411.USD","GLW","BK4588","BK4585","BK4148","BK4512"],"gpt_icon":0},{"id":"2439618603","title":"康宁公司：摩根大通将目标价从37美元上调至43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439618603","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439618603?lang=zh_cn&edition=full","pubTime":"2024-05-30 17:15","pubTimestamp":1717060546,"startTime":"0","endTime":"0","summary":"康宁公司：摩根大通将目标价从37美元上调至43美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405301715519f048705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405301715519f048705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLW"],"gpt_icon":0},{"id":"2439861860","title":"康宁公司：摩根大通从中性上调至增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2439861860","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439861860?lang=zh_cn&edition=full","pubTime":"2024-05-30 17:15","pubTimestamp":1717060544,"startTime":"0","endTime":"0","summary":"康宁公司：摩根大通从中性上调至增持","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405301715449f0486dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405301715449f0486dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLW","LU0348723411.USD","BK4588","BK4512","BK4148","BK4585"],"gpt_icon":0},{"id":"2439544629","title":"一则公告，股价暴跌近45%！康宁杰瑞进入渡劫时刻？","url":"https://stock-news.laohu8.com/highlight/detail?id=2439544629","media":"财华社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439544629?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:53","pubTimestamp":1716979995,"startTime":"0","endTime":"0","summary":"5月29日,康宁杰瑞制药-B（09966.HK）早盘突然遭遇“跳崖式”下跌，盘中一度跌至2港元，创历史新低，截至收盘，跌幅达44.75%，报2.63港元。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202405_1/c760b774-7e2e-4739-9d86-f1aa4d6afe23.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202405_1/c760b774-7e2e-4739-9d86-f1aa4d6afe23.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6657091b53243c0dd2af9f73","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK4512","LU0348723411.USD","GLW","BK4585","BK4148","BK4588"],"gpt_icon":0},{"id":"2439921765","title":"胰腺癌双抗临床失败，康宁杰瑞核心抗癌药遭重挫，盘中暴跌超40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439921765","media":"时代周报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439921765?lang=zh_cn&edition=full","pubTime":"2024-05-29 14:41","pubTimestamp":1716964879,"startTime":"0","endTime":"0","summary":"2023年11月中旬，在KN046-303试验期中分析结果发布前，康宁杰瑞的股价连续大跌。而据年报披露的数据，截至2023年年末，康宁杰瑞已动用全球发售所得款项中的8.45亿港元，用于KN046的研发和商业化。备受关注的重磅项目爆雷后，康宁杰瑞如何通过现有项目重建市场信心，仍有待观察。5月29日，康宁杰瑞开盘即大跌，盘中一度暴跌超40%。截至午间收盘，康宁杰瑞报2.86港元/股，跌39.92%，总市值为27.60亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052914413695736f9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052914413695736f9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLW","LU0348723411.USD","BK4588","BK4512","BK4148","BK4585"],"gpt_icon":0},{"id":"2439259838","title":"一年“闪崩”三次，康宁杰瑞的“癌王”适应症还是失败了 ","url":"https://stock-news.laohu8.com/highlight/detail?id=2439259838","media":"华尔街见闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439259838?lang=zh_cn&edition=full","pubTime":"2024-05-29 13:59","pubTimestamp":1716962387,"startTime":"0","endTime":"0","summary":"$康宁$杰瑞，这次终于迎来了胰腺癌的最终“审判”。这意味着作为核心管线的KN046在PDAC适应症上的临床失败。在2023年11月14日，康宁杰瑞股价开盘不久遭遇众多卖盘，股价一路下跌，最大跌幅接近30%。当时市场传言, 康宁杰瑞KN046的胰腺癌最新临床结果已经提前泄露，有内幕资金抢跑。同时也宣布AK112在国内获批EGFR-TKI治疗进展的局部晚期或转移性非鳞状非小细胞肺癌适应症。","market":"hk","thumbnail":"https://static.tigerbbs.com/c20f6e0ba4a7dd3181d84607751fb337","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c20f6e0ba4a7dd3181d84607751fb337"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3716009","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3716009","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["BK4512","BK4148","GLW","LU0348723411.USD","BK4588","BK4585"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.corning.com","stockEarnings":[{"period":"1week","weight":-0.0347},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.1787},{"period":"6month","weight":0.2678},{"period":"1year","weight":0.0919},{"period":"ytd","weight":0.2608}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.041},{"period":"3month","weight":0.057},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.2371},{"period":"ytd","weight":0.1551}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"康宁公司成立于1936年12月在纽约州成立，公司名称于1989年4月28日由康宁玻璃厂改为康宁公司。康宁公司是世界领先的专业玻璃和陶瓷制造商。170多年来，康宁将其在玻璃科学、陶瓷科学和光学物理领域无与伦比的专业知识与深厚的制造和工程能力相结合，开发出能够改变行业、提升人们生活的定义类别的产品。康宁的市场包括光通信、移动消费电子产品、显示、汽车、太阳能、半导体和生命科学。康宁的行业领先产品包括用于移动设备的耐损伤盖板玻璃；用于先进显示器的精密玻璃；用于最先进通信网络的光纤和电缆、无线技术和连接解决方案；加速药物发现和交付的可信产品；以及用于汽车和卡车的清洁空气技术。康宁在15个国家的124家工厂生产产品，并在五个可报告的部门开展业务：光通信、显示技术、特种材料、环境技术和生命科学。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.037814},{"month":2,"riseRate":0.568182,"avgChangeRate":-0.000324},{"month":3,"riseRate":0.659091,"avgChangeRate":0.03063},{"month":4,"riseRate":0.511111,"avgChangeRate":0.009335},{"month":5,"riseRate":0.577778,"avgChangeRate":0.013609},{"month":6,"riseRate":0.577778,"avgChangeRate":0.010851},{"month":7,"riseRate":0.422222,"avgChangeRate":-0.014104},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.005745},{"month":9,"riseRate":0.477273,"avgChangeRate":-0.01259},{"month":10,"riseRate":0.5,"avgChangeRate":0.003472},{"month":11,"riseRate":0.704545,"avgChangeRate":0.060649},{"month":12,"riseRate":0.5,"avgChangeRate":0.004405}],"exchange":"NYSE","name":"康宁","nameEN":"Corning"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康宁(GLW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康宁(GLW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康宁,GLW,康宁股票,康宁股票老虎,康宁股票老虎国际,康宁行情,康宁股票行情,康宁股价,康宁股市,康宁股票价格,康宁股票交易,康宁股票购买,康宁股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康宁(GLW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康宁(GLW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}